๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis
NCT07246564Myasthenia Gravis
UCB Biopharma SRL
Phase 4
40
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Jinan, Shanghai, Shenzhen
2025-12-01
Recruiting
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
NCT07435454Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Jiangsu Cancer Institute & Hospital
Phase 2
22
Nanjing
2025-12-01
Recruiting
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
NCT07243691Hepatocellular Carcinoma
Sir Run Run Shaw Hospital
Not applicable
33
Hangzhou
2025-12-01
Not yet open
Mecobalamin in Promoting Recurrent Laryngeal Nerve Function Recovery After Thyroid Surgery
NCT07274696Patients Undergoing Open Thyroid Surgery
West China Hospital
Phase 3
528
Chengdu
2025-12-01
Active, closed
Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis
NCT07309705Intracranial Atherosclerosis ICAS, Hemodynamic, Stroke
Xuanwu Hospital, Beijing
Observational
400
Beijing
2025-12-01
Not yet open
Intravenous Tirofiban After Delayed Thrombolysis in Stroke
NCT07111806Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
852
Guangzhou
2025-12-01
Recruiting
WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
NCT07330050NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
31
Tianjin
2025-12-01
Not yet open
A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
NCT07208526Intrahepatic Cholangiocarcinoma (Icc), Conversion Therapy, TDTP-RECIST, GOLP Regimen
Shanghai Zhongshan Hospital
Not applicable
270
Shanghai
2025-12-01
By invitation
Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
NCT03393962Ovarian Cancer
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2025-12-01
Recruiting
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
NCT06787183Locally Advanced Rectal Cancer With Liver Metastases
Fujian Cancer Hospital
Phase 2
42
Fuzhou
2025-12-01
Not yet open
Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR
NCT07237828Breast Cancer
Du Zhenggui
Not applicable
379
Chengdu
2025-12-01
Not yet open
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis๏ผšBLMZ Chinese Cohort
NCT07268664Rifampicin Resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis, Drug-resistant Tuberculosis
Beijing Chest Hospital
Phase 3
120
Aksu, Hetian, Kashgar
2025-12-01
Recruiting
Association Between Preoperative Metformin Exposure and Postoperative Nausea and Vomiting in Patients Undergoing General Anesthesia
NCT07244575Postoperative Nausea and Vomiting
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
909
Guangzhou
2025-12-01
Recruiting
Active Locomotion of Magnetically Controlled Capsule Endoscopy in the Small Bowel: A Feasibility Study
NCT07325344Capsule Endoscopy
Shandong University
Not applicable
15
Jinan
2025-12-01
Not yet open
A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
NCT07200947SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Zhijie Wang
Phase 2
28
Beijing
2025-12-01
Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
NCT07241390Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
Eli Lilly and Company
Phase 3
7,140
Beijing, Changchun, Changde, Changzhou, Chengdu, Chongqing, Dalian, Guangzhou
2025-12-01
Active, closed
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
NCT07359248Tension Type Headache
Tongji Hospital
Not applicable
432
Wuhan
2025-12-01
Recruiting
Valsalva SBP Drop and LVOT Obstruction
NCT07483125HCM, oHCM, nHCM
Shanghai Zhongshan Hospital
Observational
800
Shanghai
2025-12-01
Recruiting
Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
NCT07252986Breast, Breast Cancer, Pathology
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
2,000
Hangzhou
2025-12-01
Recruiting
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
NCT07357571Thyroid Papillary Carcinoma, Contrast Enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
600
Guangdong, Guangzhou
2025-12-01
Recruiting
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)
NCT07755384Reflux Esophagitis
Jilin University
Observational
60
Yushu
2025-12-01
Active, closed
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis
NCT07232576Adult Patients With Moderately to Severely Active Ulcerative Colitis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
21
Guangzhou
2025-12-01
Recruiting
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
NCT07258160Solid Cancer, Lymphopenia
Second Affiliated Hospital of Soochow University
Phase 2
127
Suzhou
2025-12-01
Recruiting
Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients
NCT07259278Secondary Prevention of Coronary Heart Disease
China National Center for Cardiovascular Diseases
Not applicable
200
Beijing
2025-12-01
Active, closed
Research on the Application of Decision Tree in Child Life
NCT07325890Psychosocial Intervention, Non-Randomized Controlled Trials
Children's Hospital of Fudan University
Not applicable
40
Shanghai
2025-12-01
Recruiting
Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)
NCT04908696Glottic Carcinoma, Supraglottic Carcinoma, Subglottic Carcinoma, Pyriform Sinus Carcinoma
Eye & ENT Hospital of Fudan University
Observational
1,000
Shanghai
2025-12-01
Not yet open
Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic Stroke
NCT07232563Ischemic Stroke
Zhujiang Hospital
Phase 1
9
Guangzhou
2025-12-01
By invitation
Effects of tDCS on Fear Reversal in Patients With Anxiety Disorders
NCT07405463Anxiety Disorders
Jingchu Hu
Not applicable
140
Guangzhou
2025-12-01
Recruiting
DV+BCG in HER2-Expressing, BCG-Naรฏve High-Risk NMIBC
NCT07207824Bladder (Urothelial, Transitional Cell) Cancer, NMIBC
Fudan University
Phase 3
182
Shanghai
2025-12-01
Recruiting
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
NCT07235384Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd.
Phase 1
84
Beijing, Jinan, Shanghai, Hangzhou
2025-12-01
Recruiting
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
NCT07182682Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Phase 3
360
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-12-01
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache
NCT07347730Myofascial Trigger Points, Cervicogenic Headache, Dorsal Root Ganglion
Beijing Tiantan Hospital
Not applicable
1,036
Beijing
2025-12-01
Recruiting
A Trial of Shengmai Liquid for Long COVID Fatigue.
NCT06980636Long COVID Fatigue
Beijing University of Chinese Medicine
Phase 4
100
Beijing
2025-12-01
Recruiting
Eye-Brain-Kidney in CKD
NCT07358572Chronic Kidney Diseases
Beijing Friendship Hospital
Observational
1,500
Beijing
2025-12-01
Recruiting
TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy
NCT07330037NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2
41
Tianjin
2025-12-01
Recruiting
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
NCT07347951Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Wenzhou Medical University
Phase 2
30
Wenzhou
2025-12-01
Recruiting
Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome
NCT07312864Liver Failure, Small-for-Size Syndrome
Beijing Friendship Hospital
Phase 1/2
12
Beijing
2025-12-01
Recruiting
Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy
NCT06728826Atrial Fibrillation (AF), Cardiac Events, Pericardial Effusion
Changhai Hospital
Not applicable
650
Shanghai
2025-12-01
Not yet open
Efficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation
NCT07239492Hypertension, Hypotension
Xuanwu Hospital, Beijing
Not applicable
25
Beijing
2025-12-01
Not yet open
EFG vs IVIG in TAMG
NCT07231523Efgartigimod, Intravenous Immunoglobulin, Myasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital
Phase 3
64
Shanghai
2025-12-01
Not yet open
A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma
NCT07239986Hepatocellular Carcinoma (HCC)
Broadenbio Ltd., Co.
Phase 2
60
Hefei, Shanghai
2025-12
Not yet open
A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography
NCT07292896Healthy Adults, Pulmonary Hypertension, Tricuspid Regurgitation, Heart Failure
First Hospital of China Medical University
Observational
2,640
Chongqing, Shenzhen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Xiangyang, Changchun
2025-12
Not yet open
A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
NCT07302035Bacterial Vaginosis
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Shanghai
2025-12
Not yet open
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
NCT07238959Benign Prostate Hypertrophy(BPH), Prostate Cancer (Diagnosis), Prostate Neoplasm
Shanghai Changzheng Hospital
Observational
1,100
Beijing, Guangzhou, Nanjing, Suzhou, Shanghai, Chengdu, Ningbo
2025-12
Not yet open
Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)
NCT07266051NMOSD
Xiamen Hospital of Traditional Chinese Medicine
Observational
4,000
Xiamen
2025-12
Not yet open
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
NCT07254858HR+/HER2- Breast Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase 2
302
Wenzhou
2025-12
Not yet open
Sac-TMT Plus Bevacizumab as Second-Line Treatment for Advanced Non-Squamous Non-Small Cell Lung Cancer
NCT07244926Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
31
Tianjin
2025-12
Recruiting
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
NCT07261683Ovarian Cancer, Immunotherapy, Pembrolizumab
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
20
Shanghai
2025-12
Not yet open
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors
NCT07291050Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
40
Beijing
2025-12
By invitation
Efficacy of Three Gingival Displacement Methods
NCT07282977Tooth Defect, Teeth Restoration
Henan Provincial People's Hospital
Not applicable
39
Zhengzhou
2025-12
Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery
NCT07311369Moderate to Severe Acute Postoperative Pain
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 2
40
Changsha
2025-12
Recruiting
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
NCT07230483Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd
Phase 2
246
Beijing
2025-12
Not yet open
Sedation of Remazolam Combined With Afentanil in Non-intubated Thoracoscopic Pulmonary Surgery
NCT06810843Pulmonary Nodule Cm
Qianfoshan Hospital
Not applicable
390
Jinan
2025-12
Recruiting
TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors
NCT07266298Solid Metastatic Tumor
Neowise Biotechnology
Phase 1
24
Beijing
2025-12
Not yet open
Proprioceptive Training for Gait and Knee Function After Anterior Cruciate Ligament Reconstruction
NCT07268651Anterior Cruciate Ligament Reconstruction
Universiti Sains Malaysia
Not applicable
30
Leshan
2025-12
Not yet open
A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease
NCT07301502Alzheimer' s Disease
Akeso
Phase 1
108
Hefei
2025-12
Not yet open
Effects of Compound Ejiao Syrup on Exercise Tolerance and Quality of Life in Critically Ill Patients After ICU Discharge: A Double-Blind, Multicenter,Randomized Controlled Clinical Study
NCT07157748Critically Ill Patients
Third Military Medical University
Not applicable
178
Chongqing
2025-12
Not yet open
Impact of Computer-aided Detection System on the Proximal Adenoma Miss Rate
NCT07308743Colon Adenomas, Colon Polyps, Sessile Serrated Lesion
Nanfang Hospital, Southern Medical University
Not applicable
686
Guangzhou
2025-12
Recruiting
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
NCT07474103Rectal Cancer, Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
49
Wuhan
2025-11-30
Not yet open
Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)
NCT07230158Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
160
Beijing
2025-11-30
Recruiting
Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China
NCT07271342Stroke
Beijing Tiantan Hospital
Observational
10,000
Beijing
2025-11-30
Recruiting
TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
NCT07246304Small Cell Lung Cancer ( SCLC ), CAR-T Cell Therapy
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1
24
Nanjing
2025-11-30
Not yet open
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
NCT07268794Metastatic Prostate Cancer, Prostate Cancer (Adenocarcinoma), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Fudan University
Phase 2
112
Shanghai
2025-11-30
Not yet open
Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage
NCT07249853Aneurysmal Subarachnoid Hemorrhage
Beijing Tiantan Hospital
Phase 3
316
Beijing
2025-11-30
Not yet open
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT07116928T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 4
1,244
Shanghai
2025-11-30
Recruiting
The Physiological Effect of RCexp on Ventilation/Perfusion Distribution
NCT06919484Acute Respiratory Distress Syndrome, Mechanical Ventilation
Southeast University, China
Observational
60
Nanjing
2025-11-30
Recruiting
The Safety and Efficacy of NouvSoma001 in Ischemic Stroke
NCT06612710Ischemic Stroke
Wei Wang
Phase 1
69
Wuhan
2025-11-30
By invitation
Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy
NCT07327710Peripheral Facial Palsy, Pulsed Radiofrequency, Brain-Computer Interface, Transcranial Direct Current Stimulation
Nanjing Medical University
Not applicable
30
Changzhou
2025-11-30
Not yet open
Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
NCT06177522Pancreatic Cancer, Neoadjuvant Therapy
Jinling Hospital, China
Phase 2
30
Nanjing
2025-11-30
Active, closed
A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
NCT07053137Systemic Lupus Erythematosus, Telitacicept, Belimumab, Efficacy and Safety
Yipeng Liu
Observational
180
Jinan
2025-11-30
Recruiting
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
NCT07441291B ALL, Allogenetic Hematopoietic Stem Cell Transplantation, MRD-positive
Peking University People's Hospital
Phase 3
70
Beijing
2025-11-30
Not yet open
A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms
NCT07234045Relapsed/Refractory B-cell Non-Hodgkin Lymphoma, Relapsed/Refractory B-cell ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
30
Tianjin
2025-11-30
Recruiting
Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score
NCT07208864Gastric Intestinal Metaplasia
Qilu Hospital of Shandong University
Not applicable
8
Jinan
2025-11-30
Recruiting
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
NCT07257640Hematologic Diseases, Neoplasms
Zhejiang University
Phase 1
20
Hangzhou
2025-11-30
Recruiting
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
NCT07274774Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2
184
Jinan
2025-11-30
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146Small-cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Hefei, Fuzhou, Xiamen, Guangzhou, Naning, Heilongjiang, Shijiazhuang, Zhengzhou
2025-11-30
Recruiting
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
NCT07255963DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
29
Suzhou
2025-11-30
Recruiting
Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.
NCT07201688Acute Ischemic Stroke
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
Phase 3
890
Puyang
2025-11-30
Recruiting
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC
NCT07239661Non-Small Cell Lung Cancer, Electroacupuncture, PD-1 Inhibitors, ECOG PS 2 Points
Kong Fanming
Not applicable
120
Tianjin
2025-11-30
Recruiting
A Multicenter Study of CAR-T Cells in Primary Ph+All
NCT07252336ALL
Zhejiang University
Phase 2
50
Hangzhou
2025-11-30
Recruiting
Robot-Assisted vs Manual Transradial Cerebral Angiography
NCT07696936Angiography, Digital Subtraction, Robot-assisted Therapy
The First Hospital of Hebei Medical University
Not applicable
156
Shijiazhuang
2025-11-30
Not yet open
Rehabilitation Exercise Intervention for Rheumatoid Arthritis Patients Using Artificial Intelligence-Based Exercise Prescription System
NCT07246811Rheumatoid Arthritis (RA)
Peking University Third Hospital
Not applicable
147
Beijing
2025-11-30
Recruiting
Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Undergoing Thoracic Surgery: A Randomized Controlled Pilot Study
NCT07250230Nicotine Dependence, Thoracic Diseases, Analgesia
Henan Provincial People's Hospital
Not applicable
80
Zhengzhou
2025-11-30
Recruiting
A Phase โ…กa Clinical Study of CL-197 Capsules
NCT07308782HIV-1 Infection
Henan Genuine Biotech Co., Ltd.
Phase 2
24
Beijing
2025-11-29
Recruiting
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
NCT07259070DLBCL, CLL, FL, MCL
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
20
Tianjin
2025-11-29
Recruiting
Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients
NCT06911489Solid Tumor Malignancy
Chengdu New Radiomedicine Technology Co. LTD.
Phase 1
132
Shanghai, Tianjin
2025-11-29
Recruiting
The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NCT06909773Cardiovascular Diseases
AstraZeneca
Not applicable
3,000
Anqing, Beijing, Changsha, Chaohu, Chengdu, Chifeng, Chongqing, Dalian
2025-11-28
Recruiting
Feasibility Study of Diaphragm Synchronized Pacing (DSP) Via the Left Inferior Phrenic Vein (LIPV) Approach
NCT07392749Heart Failure
RenJi Hospital
Not applicable
10
Shanghai
2025-11-28
Recruiting
Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy
NCT07397819Malignant Ascites
Dong sheng Zhang
Phase 1/2
48
Guangzhou
2025-11-28
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Changde, Guangzhou, Hangzhou, Jiangmen, Luoyang
2025-11-28
Recruiting
Spectral Precise Image Study for Brain Tumors
NCT07620470Brain Tumors
Philips Clinical & Medical Affairs Global
Observational
120
Wuhan
2025-11-28
Recruiting
Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting
NCT07236814Influenza
Capital Medical University
Phase 3
384
Beijing
2025-11-28
Recruiting
A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
NCT07220538Ischemic Stroke Hospitalized, Impairment, Cognitive
Dr. Willmar Schwabe GmbH & Co. KG
Phase 4
400
Anyang, Baotou, Beijing, Beipiao, Benxi, Chenzhou, Chifeng, Dalian
2025-11-28
Recruiting
Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers
NCT07240636Healthy Volunteers
Vigonvita Life Sciences
Phase 1
16
Hefei
2025-11-28
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
NCT06994845Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals
Phase 3
31
Hangzhou, Beijing
2025-11-27
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
NCT07278336Ovarian Cancer
AbbVie
Phase 1
219
Guangzhou, Jinan, Shanghai
2025-11-27
Recruiting
A Phase โ… /โ…กa Clinical Study of GEN-725 in Combination With Dositinib
NCT07362940Non-Small Cell Lung Cancer
Henan Genuine Biotech Co., Ltd.
Phase 1/2
110
Beijing, Changsha, Jinan, Xiamen, Zhengzhou
2025-11-27
Recruiting
A Study of MHB042C in Patients With Advanced Solid Tumors
NCT07192107Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
200
Guangzhou
2025-11-27
Recruiting
Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)
NCT07166211Chronic Spontaneous Urticaria (CSU)
Keymed Biosciences Co.Ltd
Phase 2
48
Tianjin
2025-11-27
Recruiting
FL-261 Imaging for Cancer Diagnosis and Staging
NCT07510321Non-Small Cell Lung Cancer, Colorectal Cancer, Head & Neck Cancer, Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
12
Wuhan
2025-11-27
Rows per page Showing 5101–5200 of 19052
Previous 50 51 52 53 54 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=52

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.